These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23000317)

  • 1. The paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic research.
    Garelnabi M; Lor K; Jin J; Chai F; Santanam N
    Clin Biochem; 2013 Jan; 46(1-2):12-9. PubMed ID: 23000317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoprotein A-V: an important regulator of triglyceride metabolism.
    Kluger M; Heeren J; Merkel M
    J Inherit Metab Dis; 2008 Apr; 31(2):281-8. PubMed ID: 18415697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common functional variants of APOA5 and GCKR accumulate gradually in association with triglyceride increase in metabolic syndrome patients.
    Hadarits F; Kisfali P; Mohás M; Maász A; Duga B; Janicsek I; Wittmann I; Melegh B
    Mol Biol Rep; 2012 Feb; 39(2):1949-55. PubMed ID: 21643755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOA5 gene variation interacts with dietary fat intake to modulate obesity and circulating triglycerides in a Mediterranean population.
    Sánchez-Moreno C; Ordovás JM; Smith CE; Baraza JC; Lee YC; Garaulet M
    J Nutr; 2011 Mar; 141(3):380-5. PubMed ID: 21209257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into apolipoprotein A5 in controlling lipoprotein metabolism in obesity and the metabolic syndrome patients.
    Su X; Kong Y; Peng DQ
    Lipids Health Dis; 2018 Jul; 17(1):174. PubMed ID: 30053818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of apolipoprotein A5 haplotypes on the ratio of triglyceride to high-density lipoprotein cholesterol and the risk for metabolic syndrome in Koreans.
    Cha S; Yu H; Park AY; Song KH
    Lipids Health Dis; 2014 Mar; 13():45. PubMed ID: 24618354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two independent apolipoprotein A5 haplotypes modulate postprandial lipoprotein metabolism in a healthy Caucasian population.
    Moreno-Luna R; Perez-Jimenez F; Marin C; Perez-Martinez P; Gomez P; Jimenez-Gomez Y; Delgado-Lista J; Moreno JA; Tanaka T; Ordovas JM; Lopez-Miranda J
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2280-5. PubMed ID: 17356049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.
    Yang G; Lei MM; Yu CL; Liu XX; An Z; Song CL
    Lipids Health Dis; 2015 Sep; 14():113. PubMed ID: 26387083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein A5: Extracellular and Intracellular Roles in Triglyceride Metabolism.
    Forte TM; Ryan RO
    Curr Drug Targets; 2015; 16(12):1274-80. PubMed ID: 26028042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein A5 T-1131C variant and risk for metabolic syndrome in obese adolescents.
    Zaki M; Amr K
    Gene; 2014 Jan; 534(1):44-7. PubMed ID: 24161374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The APOA5 Trp19 allele is associated with metabolic syndrome via its association with plasma triglycerides.
    Dallongeville J; Cottel D; Wagner A; Ducimetière P; Ruidavets JB; Arveiler D; Bingham A; Ferrières J; Amouyel P; Meirhaeghe A
    BMC Med Genet; 2008 Sep; 9():84. PubMed ID: 18789138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between sequence variant of c.553 G > T in the apolipoprotein A5 gene and metabolic syndrome, insulin resistance, and carotid atherosclerosis.
    Chien KL; Hsu HC; Chen YC; Su TC; Lee YT; Chen MF
    Transl Res; 2009 Sep; 154(3):133-41. PubMed ID: 19665689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of apolipoprotein A-V on plasma triglyceride, lipoprotein size, and composition in genetically engineered mice.
    Nelbach L; Shu X; Konrad RJ; Ryan RO; Forte TM
    J Lipid Res; 2008 Mar; 49(3):572-80. PubMed ID: 18056685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haplotype analysis of the apolipoprotein A5 gene in obese pediatric patients.
    Horvatovich K; Bokor S; Baráth A; Maász A; Kisfali P; Járomi L; Polgár N; Tóth D; Répásy J; Endreffy E; Molnár D; Melegh B
    Int J Pediatr Obes; 2011 Jun; 6(2-2):e318-25. PubMed ID: 20883102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of apolipoprotein A5.
    Tai ES; Ordovas JM
    Curr Opin Lipidol; 2008 Aug; 19(4):349-54. PubMed ID: 18607181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the distribution of plasma HDL subclasses and the polymorphisms of APOA5 in hypertriglyceridemia.
    Long S; Chen Z; Han Y; Christopher DM; Zhang C; Yang Y; Tian Y
    Clin Biochem; 2013 Jun; 46(9):733-9. PubMed ID: 23499587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein A-V dependent modulation of plasma triacylglycerol: a puzzlement.
    Sharma V; Ryan RO; Forte TM
    Biochim Biophys Acta; 2012 May; 1821(5):795-9. PubMed ID: 22209939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Apolipoprotein A5 gene: association with triglyceride metabolism and cardiovascular disease].
    Oliveira Sousa M; Alía P; Pintó X
    Med Clin (Barc); 2008 May; 130(20):787-93. PubMed ID: 18579034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of apolipoprotein A5 in obesity and the metabolic syndrome.
    Zheng XY; Zhao SP; Yan H
    Biol Rev Camb Philos Soc; 2013 May; 88(2):490-8. PubMed ID: 23279260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes.
    Qi L; Liu S; Rifai N; Hunter D; Hu FB
    Atherosclerosis; 2007 May; 192(1):204-10. PubMed ID: 16781717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.